Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "ATTLAS Study of Atezolizumab + Bevacizumab & Chemo in Patients With EGFR or ALK Mutations in NSCLC"

186 views
November 10, 2023
Comments 0
Login to view comments. Click here to Login